-
Whitepaper: Life Sciences – 409A valuation vs. valuation to raise money
The US Internal Revenue Code has numerous regulations which must be adhered to in order … Read more
-
Whitepaper: Collaboration of Venture Valuation and Ferring Pharmaceuticals
Switzerland, March 2019: Venture Valuation has been working with Ferring Pharmaceutical supporting the company with … Read more
-
Whitepaper: The Rise of Bigger, Earlier M&A Deals for Biotech
Continuing a trend that began in 2017, this year has seen the rise of big … Read more
-
Whitepaper: Focus on the Antibiotics Market
The antibiotics market is expected to reach USD 57.0 billion by 2024. Rising prevalence of … Read more
Category: Whitepapers
Archive
Categories
- Let’s Interview Series (53)
- News (45)
- Other Documents (12)
- Presentations (100)
- Reports and analyses (53)
- Whitepapers (4)
- Interviews with leading Life Sciences companies: Human Life Cord
- Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation
- A Formula for Drug Licensing Deals
- Interviews with leading Life Sciences companies: Sonire Therapeutics
- Venture Valuation/Biotechgate and AdvaMed Team Up to Drive MedTech Industry Growth
Category Tags
409A valuation AI Medical Service AOT asset valuation Biotech firms Biotechgate Biotechgate Digital Partnering brain activity measuring breast cancer Cells clinical trial database Cold Ablation Robotguided Laser Osteotome cranio-maxillofacial surgery Cyrill Bätscher early digestive track cancer detection Ferring Pharmaceutical filming Fujieda Ayumi Funding future of life sciences Gergely Ivanyi German Biotech German Life Sciences GTAI Health Made in Germany Heartseed Inc. HelloPartnering in-licensing opportunities JPM San Francisco Kiyoshi Hasegawa life science database Lily MedTech Inc. medical image analysis NeU Corporation patrik frei product valuation RESI Rhine-Main-Neckar biotech SARS CoV 2 Shiho Azuma Tomohiro Tada valuation Valuation Experts XB-01 Yone Production Co Ltd
